BLMS.US Bloomios Inc

Healthcare Pharmaceuticals USA Stocks
0.0003 USD
Close of Oct 6, 2026
0.0001 0.0003
Market cap
USD 19.3K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is BLMS.US undervalued?

Graham number

The Graham number of Bloomios Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bloomios Inc fundamental analysis

No fundamental analysis for Bloomios Inc yet.

Bloomios Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bloomios Inc

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is he…

Full company profile